fbpx

14th Annual Congress on Controversies in Ophthalmology

(COPHy) taking place in Lisbon, Portugal, March 24-25, 2023

Get more info

Dec 5, 2022

Putting stem cell-based therapies in context

Karen M. Wai, M.D., Theodore Leng, M.D., MS, and Jeffrey Goldberg, M.D., Ph.D., Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California. 

In recent years, the potential of stem cell-based therapies to treat a wide range of medical conditions has given hope to patients in search of novel treatments or cures. At the same time, thousands of rogue clinics have sprung up across the U.S. and around the world, offering stem cell-based therapies before being tested for safety and efficacy. When communicating to the public about stem cell-based therapies, it is important to put any treatment claims in context.

Over the past three decades, the Food and Drug Administration (FDA) has approved several stem cell-based products. These include bone marrow transplants, which have been transformational for many cancer patients, and therapies for blood and immune system disorders.1 …..

Read more: https://www.nei.nih.gov/about/news-and-events/news/putting-stem-cell-based-therapies-context

Source: NEI/NIH

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.